Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. - Wikidata - wikimedia - TriplyDB

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

http://www.wikidata.org/entity/Q36389413

about

Cancer cachexia--pathophysiology and management Japanese herbal medicine in functional gastrointestinal disorders.The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: a national cross-sectional survey S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1 Administration of exogenous acylated ghrelin or rikkunshito, an endogenous ghrelin enhancer, improves the decrease in postprandial gastric motility in an acute restraint stress mouse model.Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP.Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.Effects of Kampo on functional gastrointestinal disorders.Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: a systematic review.The herbal medicine rikkunshito exhibits strong and differential adsorption properties for bile salts.Rikkunshito and ghrelin.

P2860

Q24605567-8352BB5C-B8FE-40E8-B832-1B9EC6617428 Q34143122-5E5DA95D-F9D8-436A-BA58-18392C4EC25B Q34483395-F066666B-C6C0-45A2-8BC8-41A72B32E2A7 Q34675807-1063953C-BCCB-4386-93EA-10FD81177CC7 Q34848481-515A9C37-C83A-42F9-84C7-B2AB24D57BA1 Q35556669-06773B8B-A72D-4F1F-B99D-18100761F4B0 Q35662036-12EACF45-2B04-48C5-A59A-B8245BECC8BC Q35687667-04DE342A-3CD0-4996-8FF2-9C95D97B34D4 Q35844223-1F0E456E-35EB-4DAA-B5FD-17675B24BAD7 Q37532337-FA4DF69F-8E3D-42F1-AB33-8E0B34570A17 Q37691031-91C06E29-BF7D-4744-9822-9EAF6857B921 Q42112666-2066EA8E-CA8F-4237-B698-DE5221F54A78 Q42583175-F4F7D3C7-6B1B-4777-BEF2-7FA050B492A9

P2860

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

http://www.wikidata.org/entity/Q36389413

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

@ast

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

@en

type

label

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

@ast

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

@en

prefLabel

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

@ast

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

@en

P1433

Q36389413-7093F0B4-3DDE-4356-BCDC-0C39BD66C54F

P1476

Q36389413-CACC0825-BD28-4E8B-B533-D8C4B839A94D

P2093

Q36389413-23D2266C-F60F-4EB3-9974-A05BD4975F0E

Q36389413-2466C942-67EA-4D55-9E02-966323CBD301

Q36389413-877B5FE6-1179-4A5B-A9BB-769ADA55F73A

Q36389413-CC709AFD-644F-4FD3-8360-4D5D166946A2

Q36389413-D42897FB-54DA-4F9F-8795-080C19289AD5

Q36389413-EFDC6667-FA9D-423E-B314-F60DC983A481

P2860

Q36389413-1416FC74-69CC-4EF7-BD2B-CB15F40E4F68

Q36389413-5E2A8E91-1234-4CF6-AEAA-C1DDAC069F8B

Q36389413-78FEE237-3251-48D4-B298-DDE7E88BFCE2

Q36389413-8FE882E5-5E5B-427E-A356-0C345BD208B2

Q36389413-95374F06-EAE2-4ADC-840C-4D477829420E

Q36389413-B4DB392C-DD76-48C2-9154-FE8330316DBE

Q36389413-C1060E53-1C6A-41E6-A46A-2E0D5DBC4F80

Q36389413-C6CBA18F-D523-4810-B4B8-229DEB71E992

Q36389413-D4BB524A-70CE-47D1-83D1-07744B275DF9

Q36389413-F6397F83-D432-413B-B40E-055D0F206AED

P2888

Q36389413-81E915C5-5BC5-4A54-868B-790DDF55AD41

P304

Q36389413-54ADB6A7-B154-4BA3-AF8F-4319E8EC30CF

P31

Q36389413-0A97E9CE-FE95-452F-BFE1-29E2827C16A5

P356

Q36389413-4B5C79C2-BCEC-45AE-B805-CDFB6EC75831

P478

Q36389413-F3977C93-7708-46B7-B52B-1282BE1B2C7A

P577

Q36389413-D2C782B9-727F-454E-AB90-CF04D435B3CA

P5875

Q36389413-850774ED-AC1B-4C03-A0A1-CE87F806273D

P6179

Q36389413-192EA86E-FA17-4679-BFB5-C5F0E9CAC200

P698

Q36389413-51579AF0-DAC0-4465-B520-EB944A6FF4BE

P932

Q36389413-52C1E430-0CDB-489D-BB4A-D8CEF688E077

P356

P1433

BioPsychoSocial Medicine

P1476

Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

@en

P2093

Naoki Kodama

http://www.w3.org/2001/XMLSchema#string

Sadatoshi Tsuji

http://www.w3.org/2001/XMLSchema#string

Sota Hayashida

http://www.w3.org/2001/XMLSchema#string

Takakazu Oka

http://www.w3.org/2001/XMLSchema#string

Yoko Tamagawa

http://www.w3.org/2001/XMLSchema#string

Yuko Kaneda

http://www.w3.org/2001/XMLSchema#string

P2860

A SELF-RATING DEPRESSION SCALE

The herbal medicine Rikkunshi-to stimulates and coordinates the gastric myoelectric activity in post-operative dyspeptic children after gastrointestinal surgery.

Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs.

Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors.

A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.

Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.

A traditional herbal medicine, rikkunshi-to (TJ-43), prevents intracellular signaling disorders in gastric smooth muscle of diabetic rats.

Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine.

Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease.

[Successful antiemetic treatment of TSUMURA Rikkunshi-to Extract Granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient]

P2888

P304

21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1751-0759-1-21

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5846450

http://www.w3.org/2001/XMLSchema#string

P6179

1010810739

http://www.w3.org/2001/XMLSchema#string

P698

18001480

http://www.w3.org/2001/XMLSchema#string

P932

2204024

http://www.w3.org/2001/XMLSchema#string